AnalystsSam EiberSam Eiber's Stock Forecasts
AnalystsSam Eiber
Analyst Ranking
Top 31%
#1696 out of 5511 analysts
Average Return
+3.54%
Win Rate
48%14 out of 29
Risk vs Reward
Poor
Good
Sam Eiber's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Evolus IncEOLS | +55.71% | $5.08 | $7.91 | 2026-01-22 - 2026-09-15 | Strong Buy |
Sbc Medical Group Holdings IncSBC | +43.89% | $3.19 | $4.59 | 2026-08-13 - 2026-09-15 | Strong Buy |
Evolus IncEOLS | +41.50% | $5.59 | $7.91 | 2026-03-04 - 2026-09-15 | Strong Buy |
Neuronetics IncSTIM | +38.61% | $2.02 | $2.80 | 2026-07-20 - 2026-09-15 | Strong Buy |
Sbc Medical Group Holdings IncSBC | +23.39% | $3.72 | $4.59 | 2026-03-06 - 2026-09-15 | Strong Buy |
Sam Eiber Analyst Color
Get additional color on Sam Eiber's coverage of popular stocks
Sam Eiber's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Brainsway LtdBWAY | 3 | Strong Buy | $20.00 | +48.59% | Reiterates | 6 days ago |
Neuronetics IncSTIM | 3 | Strong Buy | $6.00 | +114.29% | Reiterates | 7 days ago |
Establishment Labs Holdings IncESTA | 8 | Strong Buy | $103.00 | +44.10% | Reiterates | 15 days ago |
Sbc Medical Group Holdings IncSBC | 2 | Strong Buy | $8.00 | +74.29% | Reiterates | a month ago |
Merit Medical Systems IncMMSI | 3 | Strong Buy | $105.00 | +21.84% | Reiterates | a month ago |
Icu Medical IncICUI | 2 | Strong Buy | $200.00 | +28.30% | Maintains | a month ago |
Evolus IncEOLS | 6 | Strong Buy | $13.00 | +64.35% | Reiterates | 3 months ago |
Apyx Medical CorpAPYX | 2 | Strong Buy | $6.00 | +102.70% | Upgrades | 6 months ago |
Inmode LtdINMD | 2 | Hold | N/A | N/A | Downgrades | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.